Tanaka H, Umemoto M, Miichi H, Hayashi S
Research and Development Division, Rohto Pharmaceutical Co. Ltd., Osaka, Japan.
Ophthalmic Res. 1987;19(4):240-4. doi: 10.1159/000265501.
The effect of disodium cromoglycate (DSCG) on the anaphylactic reaction was re-evaluated by measuring the amount of leaked dye into tissues of rat conjunctiva 48 h after passive sensitization with IgE antibodies against ovalbumin. In the rat sensitized with mouse monoclonal IgE (titer 4), DSCG produced a dose-dependent inhibitory effect when used in a dose range between 1 and 5%; at more than 2%, the effect was statistically significant. On more severe anaphylactic reactions induced with the same antibody at titer 10, DSCG had no significant effect when applied in doses of less than 5%. On the other hand, DSCG (2%) had no significant effect on the sensitization with either rat polyclonal IgE or mouse polyclonal IgE (titer 4). These findings indicate that DSCG has a potential benefit when used in moderate anaphylactic reactions and has a strictly specific effect depending on the origin of the antibody.
通过测量在用抗卵清蛋白的IgE抗体进行被动致敏48小时后大鼠结膜组织中漏出的染料量,重新评估了色甘酸钠(DSCG)对过敏反应的影响。在用小鼠单克隆IgE(滴度4)致敏的大鼠中,当DSCG在1%至5%的剂量范围内使用时,产生了剂量依赖性抑制作用;超过2%时,该作用具有统计学意义。在用滴度为10的相同抗体诱导的更严重过敏反应中,当以低于5%的剂量应用时,DSCG没有显著作用。另一方面,DSCG(2%)对大鼠多克隆IgE或小鼠多克隆IgE(滴度4)的致敏没有显著作用。这些发现表明,DSCG在中度过敏反应中使用时具有潜在益处,并且根据抗体来源具有严格的特异性作用。